For: | Kamdje AHN, Etet PFS, Vecchio L, Tagne RS, Amvene JM, Muller JM, Krampera M, Lukong KE. New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers. World J Clin Cases 2014; 2(12): 769-786 [PMID: 25516852 DOI: 10.12998/wjcc.v2.i12.769] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v2/i12/769.htm |
Number | Citing Articles |
1 |
Janaki Ramaiah M., Vaishnave S.. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer. Gene 2018; 678: 302 doi: 10.1016/j.gene.2018.08.022
|
2 |
Xiuping Xu, Yanan Wang, Qing Wang, Shanmei LV, Guofeng Mao. Elevated expression of ELK1 promotes breast cancer cell growth and correlates with poor prognosis of breast cancer patients. Annals of Medicine & Surgery 2024; doi: 10.1097/MS9.0000000000002256
|
3 |
Ethan Rothschild, Debabrata Banerjee. Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic Opportunities. Breast Cancer: Basic and Clinical Research 2015; : BCBCR.S29423 doi: 10.4137/BCBCR.S29423
|
4 |
Mohammad Borhan Uddin, Balakavitha Balaravi Pillai, Kyi Kyi Tha, Maeirah Ashaie, Md. Emranul Karim, Ezharul Hoque Chowdhury. Carbonate Apatite Nanoparticles-Facilitated Intracellular Delivery of siRNA(s) Targeting Calcium Ion Channels Efficiently Kills Breast Cancer Cells. Toxics 2018; 6(3): 34 doi: 10.3390/toxics6030034
|
5 |
Kuo-Shyang Jeng, I-Shyan Sheen, Chuen-Miin Leu, Ping-Hui Tseng, Chiung-Fang Chang. The Role of Smoothened in Cancer. International Journal of Molecular Sciences 2020; 21(18): 6863 doi: 10.3390/ijms21186863
|
6 |
Jingpei Long, Zhiwei Ji, Kai Jiang, Zhaoyang Wang, Guanmin Meng. miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/373574
|
7 |
Aline Brito de Lima, Camila de Souza Barbosa, Alessandra Mirtes Marques Neves Gonçalves, Fabio Vieira dos Santos, Gustavo Henrique Ribeiro Viana, Fernando de Pilla Varotti, Luciana Maria Silva. New 3‐alkylpyridine marine alkaloid analogues as promising antitumor agents against the CD44+/high/CD24−/low subset of triple‐negative breast cancer cell line. Chemical Biology & Drug Design 2017; 90(1): 5 doi: 10.1111/cbdd.12923
|
8 |
Ramadevi Subramani, Sushmita B. Nandy, Diego A. Pedroza, Rajkumar Lakshmanaswamy. Role of Growth Hormone in Breast Cancer. Endocrinology 2017; 158(6): 1543 doi: 10.1210/en.2016-1928
|
9 |
Riccardo Sgarra, Silvia Pegoraro, Gloria Ros, Carlotta Penzo, Eusebio Chiefari, Daniela Foti, Antonio Brunetti, Guidalberto Manfioletti. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018; 1869(2): 216 doi: 10.1016/j.bbcan.2018.03.001
|
10 |
Shane V. Hegarty, Katie L. Togher, Eimear O’Leary, Franziska Solger, Aideen M. Sullivan, Gerard W. O’Keeffe. Romidepsin induces caspase-dependent cell death in human neuroblastoma cells. Neuroscience Letters 2017; 653: 12 doi: 10.1016/j.neulet.2017.05.025
|
11 |
Dominik Terefinko, Anna Dzimitrowicz, Aleksandra Bielawska-Pohl, Aleksandra Klimczak, Pawel Pohl, Piotr Jamroz. The Influence of Cold Atmospheric Pressure Plasma-Treated Media on the Cell Viability, Motility, and Induction of Apoptosis in Human Non-Metastatic (MCF7) and Metastatic (MDA-MB-231) Breast Cancer Cell Lines. International Journal of Molecular Sciences 2021; 22(8): 3855 doi: 10.3390/ijms22083855
|
12 |
Julian Gomez-Cambronero. Lack of effective translational regulation of PLD expression and exosome biogenesis in triple-negative breast cancer cells. Cancer and Metastasis Reviews 2018; 37(2-3): 491 doi: 10.1007/s10555-018-9753-x
|
13 |
Dominik Terefinko, Anna Dzimitrowicz, Aleksandra Bielawska-Pohl, Pawel Pohl, Aleksandra Klimczak, Piotr Jamroz. Comprehensive studies on the biological activities of human metastatic (MDA-MB-231) and non-metastatic (MCF-7) breast cancer cell lines, directly or combinedly treated using non-thermal plasma-based approaches. Toxicology in Vitro 2024; 98: 105846 doi: 10.1016/j.tiv.2024.105846
|
14 |
Mohd Nazir Mannan, Lahari Kuna, Alokananda Chakraborty, Mohammad Zakir, Syeda Hajra Fatima, Ahmed Minhajuddin, Munawwar Husain Kazmi, Tasleem Ahmad. Phytochemical investigation, antioxidant and anticancer activities of various Unani drugs. Drug Metabolism and Personalized Therapy 2023; 38(1): 107 doi: 10.1515/dmpt-2022-0110
|
15 |
Diana Behrens, Wolfgang Walther, Iduna Fichtner. Pancreatic cancer models for translational research. Pharmacology & Therapeutics 2017; 173: 146 doi: 10.1016/j.pharmthera.2017.02.013
|
16 |
Nupur Mukherjee, Chinmay Kumar Panda. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons. Clinical Breast Cancer 2020; 20(5): 361 doi: 10.1016/j.clbc.2020.04.004
|
17 |
Jamal Naderi, Fariba Samani, Alireza Amooheidari, Shaghayegh Haghjooy Javanmard, Gelareh Vahabzadeh, Golnaz Vaseghi. Evaluation of effects of morphine and ionizing radiation in cancer cell lines. Journal of Cancer Research and Therapeutics 2019; 15(Suppl 1): S144 doi: 10.4103/jcrt.JCRT_48_17
|
18 |
Kuo-Shyang Jeng, Chiung-Fang Chang, Shu-Sheng Lin. Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments. International Journal of Molecular Sciences 2020; 21(3): 758 doi: 10.3390/ijms21030758
|
19 |
Ksenia Golub, Weiyu Bai, Zhimeng Zhang, Huilin Xiao, Rongyuan Sun, Junling Shen, Jianwei Sun. The mechanism and consequences of BRAF inhibitor resistance in melanoma. Genome Instability & Disease 2023; 4(5): 266 doi: 10.1007/s42764-023-00105-5
|
20 |
Matheus H. Dias, Eduardo S. Kitano, André Zelanis, Leo K. Iwai. Proteomics and drug discovery in cancer. Drug Discovery Today 2016; 21(2): 264 doi: 10.1016/j.drudis.2015.10.004
|
21 |
Tara Boulding, Fan Wu, Robert McCuaig, Jennifer Dunn, Christopher R. Sutton, Kristine Hardy, Wenjuan Tu, Amanda Bullman, Desmond Yip, Jane E. Dahlstrom, Sudha Rao, Aamir Ahmad. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer. PLOS ONE 2016; 11(2): e0148065 doi: 10.1371/journal.pone.0148065
|
22 |
Silpa Gampala, Jer-Yen Yang. Hedgehog Pathway Inhibitors against Tumor Microenvironment. Cells 2021; 10(11): 3135 doi: 10.3390/cells10113135
|
23 |
Younghee Park, Kyu Sang Lee, So Yeon Park, Jee Hyun Kim, Eun Young Kang, Sung Won Kim, Keon Young Eom, Jae Sung Kim, In Ah Kim. Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer. Journal of Breast Cancer 2015; 18(3): 249 doi: 10.4048/jbc.2015.18.3.249
|
24 |
S. Geninatti Crich, M. Cadenazzi, S. Lanzardo, L. Conti, R. Ruiu, D. Alberti, F. Cavallo, J. C. Cutrin, S. Aime. Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells. Nanoscale 2015; 7(15): 6527 doi: 10.1039/C5NR00352K
|
25 |
A.H. Nwabo Kamdje, L. Vecchio, P.F. Seke Etet, P.T. Kamga, J.M. Muller, G. Bassi, E. Lukong, R.K. Goel, M. Krampera. Mesenchymal Stromal Cells as Tumor Stromal Modulators. 2017; : 169 doi: 10.1016/B978-0-12-803102-5.00007-0
|